Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Tissue rigidity promotes tumor progression

Tissue rigidity promotes tumor progression

September 20, 2005

Most investigations into cancer have focused on chemical signals, but a new research study provides rare insight into how mechanical force can regulate cellular behavior.

The study uncovers a link between tissue tension and tumor formation, suggesting that the stiffness of a tissue can influence molecular signals that promote the malignant behavior of tumor cells. The findings, published in the September issue of Cancer Cell, provide exciting new insight into the mechanisms that link the tissue microenvironment with tumorigenesis, and may identify new targets for tumor therapies.




Tumors are more rigid than normal tissues, and palpation of compliant tissues to look for a rigid tissue mass has been used as a method of cancer detection for some time. However, the relationship between tissue stiffness and the behavior of tumor cells is not well understood. Dr. Valerie M. Weaver, from the University of Pennsylvania in Philadelphia, and colleagues examined cancer cells developing within a three-dimensional gel system in which rigidity could be carefully controlled to look at how tissue stiffening might drive malignant behavior of cancer cells.

Research focused on a class of molecules called integrins that function as transducers of physical cues and are known to regulate growth factor signaling. The researchers found that even a slight increase in the stiffness of the surrounding matrix perturbed tissue architecture and enhanced growth by inducing Rho-generated cytoskeletal tension to promote assembly of integrin-associated attachments called focal adhesions and increase growth factor-dependent ERK activation. Further, a decrease in Rho or ERK activity in cancerous cells was associated with a subsequent decline of focal adhesions and a reversion of aberrant morphological structures.

The results of the research study provide a link between exogenous force, Rho-associated cytoskeletal tension, focal adhesions, and growth factor activation of ERK, and offer a fresh perspective for understanding the molecular basis of tissue differentiation and tumor formation. According to Dr. Weaver, "ERK and Rho appear to be part of an integrated mechanoregulatory circuit that functions to link physical cues through integrins to molecular pathways that control cell growth. A chronic increase in cytoskeletal tension could enhance growth and perturb tissue organization, thereby promoting malignant transformation of a tissue."

Cell Press



Related Tumor Progression Current Events and Tumor Progression News Articles Tumor Progression Current Events and Tumor Progression News RSS Tumor Progression Current Events and Tumor Progression News RSS
A potential targets for the prevention or treatment of esophageal carcinoma
Expression of Livin in fresh esophageal cancer tissues was detected by immunohistochemistry (IHC), Western blotting and reverse transcriptase-polymerase chain reaction (RT-PCR), VEGF by Its correlation Western blotting and RT-PCR.

Researchers identify mechanism used by gene to promote metastasis in human cancer cells
Virginia Commonwealth University Institute of Molecular Medicine and VCU Massey Cancer Center researchers have discovered how a gene, melanoma differentiation associated gene-9/syntenin (mda-9/syntenin), interacts with an important signaling protein to promote metastasis in human melanoma cells, a discovery that could one day lead to the development of the next generation of anti-metastatic drugs for melanoma and other cancers.

New approach to gene therapy may shrink brain tumors, prevent their spread
Massachusetts General Hospital (MGH) researchers are investigating a new approach to gene therapy for brain tumors - delivering a cancer-fighting gene to normal brain tissue around the tumor to keep it from spreading.

CSHL scientists identify new drug target against virulent type of breast cancer
Tumor cells in a particular subset of breast cancer patients churn out too much of a protein called ErbB2 -- also often called HER2 -- which drives the cells to proliferate unchecked. Patients unlucky enough to be in this group -- about one in four -- have poorer prognoses and clinical outcomes than those who don't.

Rheb's role in cancer
Two independent papers in the August 15th issue of G&D identify the Rheb GTPase as a novel oncogene and a promising new chemotherapeutic target.

Targeted radiation therapy can control limited cancer spread
Precisely targeted radiation therapy can eradicate all evidence of disease in selected patients with cancer that has spread to only a few sites, suggests the first published report from an ongoing clinical trial.

Experimental agent blocks prostate cancer in animal study
An experimental drug has blocked the progression of prostate cancer in an animal model with an aggressive form of the disease, new research shows.

MR imaging accurately determines prostate cancer treatment failure
Dynamic contrast-enhanced MRI (DCE-MRI) plus diffusion weighted imaging (DWI) can accurately diagnose residual or recurrent prostate cancer in patients treated with high-intensity focused ultrasonic ablation, a new study shows.

Researchers identify new cell targets for preventing growth of breast and other tumors
Researchers at the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have discovered new targets for cancer treatment aimed at blocking a key step in tumor progression.

Researchers identify new cell targets for preventing growth of breast and other tumors
Researchers at the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have discovered new targets for cancer treatment aimed at blocking a key step in tumor progression.
More Tumor Progression Current Events and Tumor Progression News Articles
Egf Receptor in Tumor Growth and Progression (Ernst Schering Research Foundation Workshop, 19)

The tyrosine kinases are frequently implicated in experimental as well as in human cancer. The best-studied receptor signaling system from this family is the EGF receptor. Experts in this area report on the involvement of the receptor in a variety of human tumors, outline underlying molecular mechanisms for aberrant receptor signaling in experimental systems and present the status of current...

Influence of the Host on Tumor Development (Cancer Growth and Progression)

...

Regulation of Hyaluronan Biosynthesis: Expression in Vitro & Importance for Tumor Progression (Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, 1148)
by Annica Jacobson



Regulation of Gene Expression in the Tumor Environment: Regulation of melanoma progression by the microenvironment: the roles of PAR-1 and PAFR (The Tumor ... (The Tumor Microenvironment)

It is now becoming very clear that the development and progression of tumor towards the malignant (metastatic) phenotype depends tightly on the interaction between the tumor cells and the tumor microenvironment. Tumor cells respond to stimuli generated within the tumor microenvironment for their growth advantage while the tumor cell themselves reshape and remodel the architecture and function of...

Targeted therapy thwarts tumor progression: sunitinib, a drug that binds to multiple enzymes, offers new hope for patients resistant to imatinib.(Digestive ... : An article from: Family Practice News
by Betsy Bates

This digital document is an article from Family Practice News, published by Thomson Gale on March 15, 2006. The length of the article is 564 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle:...

Comparative Aspects of Tumor Development (Cancer Growth and Progression)

Targeted therapy thwarts tumor progression.(gastrointestinal stromal tumors treated with sunitinib)(Drug overview): An article from: Internal Medicine News
by Betsy Bates

This digital document is an article from Internal Medicine News, published by Thomson Gale on April 1, 2006. The length of the article is 564 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle:...



Tumor Progression and Therapeutic Resistance (Annals of the New York Academy of Sciences)

The entire breadth of translational cancer research is addressed in this volume, which brings together members of academia and industry in the expectation of accelerating interactions and progress in the field. A variety of key topics are presented, beginning with discovery of molecular targets and pathways (oncogene, cell survival, tumor suppression, cell death), host-neoplasm interactions (cell...

BCC depth influenced by histologic subtype, tumor width, and male sex. (Location has no Impact).(basal cell carcinoma): An article from: Skin & Allergy News

This digital document is an article from Skin & Allergy News, published by International Medical News Group on January 1, 2002. The length of the article is 6610 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

Mathematical Modeling in Tumor Growth and Progression (Invasion and Metastasis, 4-5)
by S. Michelson

© 2008 BrightSurf.com